Related Experiment Video
Updated: Jul 2, 2026

06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients.
Jean Grant1, Katarzyna Bourcier, Stephen Wallace
1University of California San Francisco, Bethesda, Maryland 20814, USA.
Cytometry. Part B, Clinical Cytometry
|August 12, 2008
Summary
Standardizing FoxP3 antibody staining for regulatory T cells is crucial for clinical trials. This study optimized flow cytometry methods, identifying optimal reagents and protocols for reliable FoxP3 detection in various sample types.
Area of Science:
- Immunology
- Cell Biology
- Clinical Trials
Background:
- Forkhead box P3 (FoxP3) is a key marker for regulatory T cells.
- Flow cytometry is widely used for FoxP3 detection, but standardization across different antibodies and protocols is needed for clinical applications.
- Previous methods lacked standardization, impacting the reliability of FoxP3 analysis in clinical trial samples.
Purpose of the Study:
- To standardize FoxP3 antibody staining for flow cytometry in clinical trial samples.
- To evaluate and compare different FoxP3 antibodies, cell preparation methods, and fix/perm reagents.
- To validate an optimized protocol using clinical specimens from patients with autoimmune diseases.
Main Methods:
- Evaluated FoxP3 antibodies from eBioscience (236A/E7, PCH101) and BioLegend (206D).
- Assessed various cell preparation protocols, fix/perm reagents, and cell isolation procedures (Ficoll separation, washed blood).
- Validated the optimized protocol on frozen peripheral blood mononuclear cells (PBMC) from patients with multiple sclerosis (MS), type 1 diabetes, and healthy controls.
Main Results:
- BioLegend's 206D clone provided optimal FoxP3 staining.
- Fix/perm reagents from both eBioscience and BioLegend showed comparable results.
- The optimized protocol demonstrated applicability to fresh washed blood, fresh PBMC, and frozen PBMC.
- A significant increase in FoxP3 expression was observed in type 1 diabetes patients, but not in MS patients, compared to controls.
Conclusions:
- The developed protocol enables reliable assessment of FoxP3 expression by flow cytometry.
- This standardization is applicable to clinical sites analyzing fresh blood or frozen PBMC in real-time.
- The findings support the use of standardized FoxP3 staining for evaluating immune responses in autoimmune diseases.
More Related Videos
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

